Tetraphase Pharmaceuticals, Inc. (TTPH)

[Schnauzer1]

Price touching high $3.90 range. Truly an exceptional buying opportunity. Any lower and I will be buying with both hands. Why? The science is compelling; the license ownership of synthetic process is moat creating; the variant compounds are 3,000 strong potential blockbusters (no other pharma can boast this); the passage of next trial is almost guaranteed; the time to approval is about year; the cUTI is close behind and will carry Hugh commercial success if oral arm added; news any day of trial kick-off which will bump price. Stock was valued in excess of $50 based on expected passage. The guys have identified the reason for failure and have corrected for that. One year away; value should be $9 - $15. It will get there. Once it starts it will be quick!